Vimal Mehta | Chief Executive Officer |
Matt Wiley | Chief Commercial Officer |
Richard Steinhart | Vice President, Chief Financial Officer |
Rob Risinger | Chief Medical Officer, Neuroscience |
Greg Harrison | Bank of America |
Robyn Karnauskas | Truist Securities |
Sumant Kulkarni | Canaccord |
Yatin Suneja | Guggenheim Partners |
Colin Bristow | UBS |
Corinne Jenkins | Goldman Sachs |
Anita Dushyanth | Berenberg |
Good morning and welcome to the BioXcel Therapeutics first quarter 2022 financial results conference call. At this time, all participants are in a listen-only mode. If during the conference you require operator assistance, please press star, zero on your telephone keypad. After the presentation, there will be a question and answer session.
If you would like to register a question, you may press star, one on your telephone keypad.